首页 | 官方网站   微博 | 高级检索  
     

复方杠柳液外用治疗尖锐湿疣临床观察及对离体人乳头瘤病毒DNA的影响
引用本文:崔炳南,许铣,赵岩松,高炳爱,吴晓霞,张肖平.复方杠柳液外用治疗尖锐湿疣临床观察及对离体人乳头瘤病毒DNA的影响[J].中国中西医结合杂志,2005,25(5):392-396.
作者姓名:崔炳南  许铣  赵岩松  高炳爱  吴晓霞  张肖平
作者单位:1. 中国中医研究院广安门医院,北京,100053
2. 北京中医药大学
3. 中国航天总公司711医院
4. 陕西中医学院
5. 山东省海阳市中医药职业专科学校附属医院
基金项目:国家中医药管理局科研项目
摘    要:目的观察中药复方杠柳液治疗尖锐湿疣(condyloma acuminatum,CA)的临床疗效,并从分子水平探讨其作用机理。方法将81例尖锐湿疣患者,随机分为复方杠柳液(30例)、杠柳浆(21例)、尤脱欣(30例)3组,评定各组疗效及不良反应发生率。采用聚合酶链反应技术(polymerase chain reaction,PCR),检测2例离体尖锐湿疣疣体中人乳头瘤病毒(human papilloma virus,HPV)DNA经复方杠柳液及其君药杠柳浆作用后的变化。结果复方杠柳液、杠柳浆、尤脱欣3组的痊愈率分别为56.67%、42.86%、63.33%:总有效率分别为83.33%、71.43%、86.67%,3组疗效比较差异无显著性。复方杠柳液、杠柳浆、尤脱欣3组的不良反应发生率分别为6.67%、4.76%、86.67%,差异有显著性(P<0.01);复发率分别为14.3%、12.5%、47.1%。两份不同及相同浓度疣体匀浆混悬液经复方杠柳液、杠柳浆作用后PCR均阴性,未经药物处理的生理盐水组PCR均阳性。结论复方杠柳液、杠柳浆、尤脱欣3组最终疗效相近,复方杠柳液及杠柳浆组不良反应少、复发率低。该药对离体CA组织中的HPV—DNA可能有破坏作用。

关 键 词:人乳头瘤病毒DNA  尖锐湿疣  杠柳  离体  临床观察  外用治疗  不良反应发生率  聚合酶链反应技术  chain  生理盐水组  尤脱欣  中药复方  临床疗效  作用机理  分子水平  PCR)  总有效率  疗效比较  药物处理  破坏作用  显著性  复发率  痊愈率
修稿时间:2004年12月24

Clinical Efficacy of Compound Periploca Liquid in Treating Condyloma Acuminatum and Its Effect on Human Papilloma Virus DNA Expression in vitro
Authors:CUI Bing-nan  XU Xian  ZHAO Yan-song
Abstract:ObjectiveTo investigate the clinical efficacy of compound periploca liquid (CPL) in treating condyloma acuminatum (CA), and to explore its mechanisms at molecular level. MethodsEighty-one patients with CA were randomly divided into three groups, 30 patients in Group A were treated with CPL, 21 in Group B were treated with periploca syrup and 30 in Group C were treated with Youtuoxin (YXG). The clinical efficacy and adverse reaction occurred in the three groups was evaluated respectively. Besides, change of human papilloma virus (HPV) DNA in two patients with CA was determined by polymerase chain reaction (PCR) in vitro after being treated with CPL and periploca, the monarchic drug of CPL. ResultsThe cure rate obtained in group A, B, and C was 56.67%, 42.86% and 63.33% respectively, the total effective rate in them was 83.33%, 71.43% and 86.67% respectively, the difference of therapeutic efficacy was insignificant among the three groups. But the adverse reaction occurrence in them (6.67%, 4.76% and 86.67%) was significantly different (P<0.01). The recurrent rate in them was 14.29%, 12.5% and 47.1% respectively. PCR showed negative expression of HPV in the two samples of CA of same concentration after the verrucous homogenate suspension being treated with CPL or periploca syrup of different concentration, while it was positive after the suspension was treated with the group of normal saline without any drug. ConclusionThe therapeutic efficacies of CPL, periploca syrup and Youtuoxin are not significantly different, but the former two have advantages of less adverse effects and lower recurrent rate. And they are possibly having germicidal action on HPV-DNA in CA tissue in vitro.
Keywords:condyloma acuminatum  Chinese drug-therapy  compound periploca liquid  human papilloma virus  polymerase chain reaction
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号